Nalaganje...

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer’s disease

Several potential disease-modifying drugs for Alzheimer’s disease (AD) have failed to show any effect on disease progression in clinical trials, conceivably because the AD subjects are already too advanced to derive clinical benefit from treatment and because diagnosis based on clinical criteria alo...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Alzheimers Dement
Main Authors: Blennow, Kaj, Dubois, Bruno, Fagan, Anne M., Lewczuk, Piotr, de Leon, Mony J., Hampel, Harald
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4386839/
https://ncbi.nlm.nih.gov/pubmed/24795085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2014.02.004
Oznake: Označite
Brez oznak, prvi označite!